Clinuvel Pharmaceuticals Ltd. | Mutual Funds
Mutual Funds that own Clinuvel Pharmaceuticals Ltd.
Fidelity Funds SICAV - Pacific Fund
2,864,057
5.99%
-214,351
1.26%
05/31/2018
Fidelity Funds SICAV - Asian Smaller Companies Fund
324,546
0.68%
-144,105
0.43%
05/31/2018
NEF - Azionario Pacifico
120,052
0.25%
4,996
1.28%
12/31/2017
Fidelity Asian Values Plc
77,550
0.16%
-148,324
0.23%
05/31/2018
Fidelity Japan Japan/Asia Growth Equity Mother Fund
72,631
0.15%
-66,437
1.49%
12/11/2017
Fidelity Funds SICAV - FAWF Pacific Fund
42,947
0.09%
-1,231
1.28%
10/31/2017
DFA Asia Pacific Small Company Series
30,557
0.06%
0
0.02%
01/31/2018
Smith & Williamson Unit Trusts - Oriental Growth Fund
30,441
0.06%
0
1.46%
08/31/2018
Fidelity Funds SICAV - International Fund
8,769
0.02%
-418
0.01%
03/31/2018
DFA International Small Cap Growth Portfolio
8,616
0.02%
1,676
0.05%
04/30/2018
| Address |
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
|
|
Employees
|
- |
| Website |
http://www.clinuvel.com |
| Updated |
07/08/2019 |
| Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. |
